Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Design Therapeutics Inc (NQ: DSGN ) 5.200 -0.040 (-0.76%) Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 69,394 Open 5.280 Bid (Size) 2.220 (4) Ask (Size) 5.610 (3) Prev. Close 5.240 Today's Range 5.050 - 5.300 52wk Range 1.960 - 6.910 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Design Therapeutics to Participate in the 2024 Cantor Global Healthcare Conference September 10, 2024 From Design Therapeutics, Inc. Via GlobeNewswire Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones for GeneTAC™ Portfolio August 05, 2024 From Design Therapeutics, Inc. Via GlobeNewswire Performance YTD +104.72% +104.72% 1 Month +10.17% +10.17% 3 Month +11.59% +11.59% 6 Month +42.47% +42.47% 1 Year +137.44% +137.44% More News Read More The 100%+ Club: Piper Sandler’s 3 Top Picks for Triple-Digit Gains May 22, 2024 Via InvestorPlace DSGN Stock Earnings: Design Therapeutics Beats EPS for Q1 2024 May 08, 2024 Via InvestorPlace Earnings Preview For Design Therapeutics March 18, 2024 Via Benzinga Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program Milestones May 08, 2024 From Design Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Intraday Session May 07, 2024 Via Benzinga Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference May 07, 2024 From Design Therapeutics, Inc. Via GlobeNewswire Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying March 26, 2024 Via Benzinga Topics Stocks Exposures US Equities DSGN Stock Earnings: Design Therapeutics Beats EPS for Q4 2023 March 19, 2024 Via InvestorPlace Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full Year 2023 Financial Results March 19, 2024 From Design Therapeutics, Inc. Via GlobeNewswire Earnings Scheduled For March 19, 2024 March 19, 2024 Via Benzinga Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive Portfolio Update March 12, 2024 From Design Therapeutics, Inc. Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session February 09, 2024 Via Benzinga Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portfolio Update in Early 2024 November 13, 2023 From Design Therapeutics, Inc. Via GlobeNewswire Over $5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying August 31, 2023 Via Benzinga Topics Stocks Exposures US Equities Market Sentiment Teeters As US Indices, Including S&P 500, Break Key Supports: Next Levels To Watch August 17, 2023 Via Benzinga Topics Stocks Exposures US Equities Design Therapeutics' Modified DT-216 May Have Potential, But Analyst Awaits Further Developments August 15, 2023 Via Benzinga Nasdaq Falls 100 Points; Siyata Mobile Shares Spike Higher August 15, 2023 Via Benzinga Topics Stocks Exposures US Equities Why Shares of Design Therapeutics Are Plummeting on Tuesday August 15, 2023 Via The Motley Fool 12 Health Care Stocks Moving In Tuesday's Intraday Session August 15, 2023 Via Benzinga Crude Oil Down 2%; Home Depot Posts Upbeat Earnings August 15, 2023 Via Benzinga Topics Stocks Exposures Fossil Fuels US Equities Why PhenomeX Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session August 15, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 August 15, 2023 Via Benzinga Dow Falls Over 200 Points; US Retail Sales Top Expectations August 15, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
